CN106046376B — 含叔丁基b′b2型三胺单体和其超支化聚酰亚胺及制备方法
Assigned to Shanghai Mat Macromolecule Material Co ltd · Expires 2019-02-22 · 7y expired
What this patent protects
本发明公开了一种具有不等活性官能团的含叔丁基B'B 2 型三胺单体和其超支化聚酰亚胺及制备方法,所述三胺单体由对叔丁基苯胺出发,经硝化、取代、还原三步反应制备得到。基于该单体三个氨基活性的差异,其可与各种商品化二酐单体通过“两步法”制备得到超支化聚酰亚胺,而避免凝胶的发生。所制得的超支化聚酰亚胺具有良好的热稳定性和溶解性,在气体膜分离、耐高温聚合物加工等领域具有广泛的应用前景。
USPTO Abstract
本发明公开了一种具有不等活性官能团的含叔丁基B'B 2 型三胺单体和其超支化聚酰亚胺及制备方法,所述三胺单体由对叔丁基苯胺出发,经硝化、取代、还原三步反应制备得到。基于该单体三个氨基活性的差异,其可与各种商品化二酐单体通过“两步法”制备得到超支化聚酰亚胺,而避免凝胶的发生。所制得的超支化聚酰亚胺具有良好的热稳定性和溶解性,在气体膜分离、耐高温聚合物加工等领域具有广泛的应用前景。
Drugs covered by this patent
- Kalydeco (IVACAFTOR) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.